OSUR - OraSure Technologies Enterprise Value

Official company branding of OraSure Corp (OSUR)

This chart of current OraSure Technologies (OSUR) quotes on GURU.Markets indicates an Enterprise Value of 143.66. The business relies on a sustainable market moat driven by proprietary sampling systems and rapid diagnostics. In-house manufacturing plants in the US guarantee the uninterrupted production of equipment critical to medicine. A high barrier to entry is ensured by strict FDA oversight and exclusive rights to saliva-based tests.

OSUR (OraSure Technologies Inc) Total Company Value history from 11/23/2025 to 10/28/2026

OSUR (OraSure Technologies): analytical breakdowns and indicator data

- price and consensus price forecast:
Market Chart OraSure Technologies, Inc.|OSUR - Consensus Target
- market capitalization data:
Market Capitalization OraSure|OSUR - Total Company Value
- book capitalization data:
Accounting Value of a Share OraSure|OSUR - Company Book Value|Market Cap to Net Assets Ratio orasure.com|OSUR - Company Total Assets
- debt and liquidity data:
Debt to Capital OraSure Technologies|OSUR - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio orasure.com|OSUR - Company Aggregate Debts|Debts to Book Capitalization OraSure|OSUR - Company Long-Term Debt|Company Short-Term Indebtedness OraSure
Summary company analytics:OraSure Technologies, Inc. (OSUR)
Original product of OraSure Technologies, Inc.

A steady stream of molecular diagnostic orders for OraSure Technologies (OSUR) directly drives the dynamics of the business's net market price. This indicator aggregates market capitalization and debt minus liquid assets, allowing investors to assess the actual cost of acquiring the issuer and determine the assets' margin of safety relative to their debt load.

Competitor analysis

A - Company Buyout Price|Quest - Real Price to Acquire Entire Company|ILMN: Enterprise Value|Total Company Value Exact Sciences EXAS|RVTY (revvity.com) - Value Adjusted for Debt and Cash|Total Company Value BIO|Real Price to Acquire Entire Company Anbio Biotechnology Ltd|Sterigenics - Enterprise Value|Total Enterprise Value QuidelOrtho Inc. (QDEL)|OPK - Enterprise Value|Business Value CareDx Health CDNA|Maravai LifeSciences Holdings, Inc. - Enterprise Value|FLGT: Enterprise Value|Total Company Value Fluidigm|Cytek Corp (CTKB) - Business Value|XGN (Exagen Inc) - Enterprise Value|Enterprise Value MDXH|Total Company Value Lucid Diagnostics (LUCD)|Total Company Value prenetics.com PRE|IMDX: Real Price to Acquire Entire Company|Trinity Biotech PLC - Total Enterprise Value|Total Company Value PRPH (ProPhase Labs, Inc.)|AIMD - Company Buyout Price|Co-Diagnostics - Enterprise Value|HSCS (Heart Test Laboratories, Inc.) - Company Buyout Price|BMRA: Total Company Value|Company Buyout Price CDIO|Virax Biolabs Group - Total Company Value|Total Enterprise Value BJDX (bluejaydx.com)|Total Company Value Aspira Women's Health Inc.|Value Adjusted for Debt and Cash Accelerate Diagnostics Inc. AXDX|Centogene - Enterprise Value|ENZ: Enterprise Value|fresh2.co - Total Company Value|Company Buyout Price Genetic Technologies Limited|ME (23andMe) - Real Price to Acquire Entire Company|Enterprise Value PMD